Document ID: chunk:federal_register_of_legislation:F2024L01389:schedule:1:p46
Version: federal_register_of_legislation:F2024L01389
Segment Type: schedule
Provision Reference: sch 1 (pt 46/66)
Character Range: 127967–134112

C15975  P15975  CN15975  Fluconazole                  Cryptococcal meningitis                                                                                                                                                                                                                                                                                                                                                                                             Compliance with Authority Required procedures - Streamlined Authority Code 15975
                                                      The treatment must be maintenance therapy; AND
                                                      Patient must be immunosuppressed; AND
                                                      Must be treated by a health practitioner who is any of: (i) a medical practitioner, (ii) an authorised PBS prescriber who is not a medical practitioner, but who is: (a) sharing care of the patient with at least one medical practitioner; (b) intending to share care of the patient with a medical practitioner.
C15978  P15978  CN15978  Itraconazole                 Systemic sporotrichosis                                                                                                                                                                                                                                                                                                                                                                                             Compliance with Authority Required procedures - Streamlined Authority Code 15978
                                                      Must be treated by a health practitioner who is any of: (i) a medical practitioner, (ii) an authorised PBS prescriber who is not a medical practitioner, but who is: (a) sharing care of the patient with at least one medical practitioner; (b) intending to share care of the patient with a medical practitioner.
C15979  P15979  CN15979  Voriconazole                 Serious Candida infections                                                                                                                                                                                                                                                                                                                                                                                          Compliance with Authority Required procedures
                                                      Treatment and maintenance therapy
                                                      The condition must be caused by species not susceptible to fluconazole; or
                                                      The condition must be resistant to fluconazole; or
                                                      Patient must be unable to tolerate fluconazole; AND
                                                      Must be treated by a health practitioner who is any of: (i) a medical practitioner, (ii) an authorised PBS prescriber who is not a medical practitioner, but who is: (a) sharing care of the patient with at least one medical practitioner; (b) intending to share care of the patient with a medical practitioner.
C15981  P15981  CN15981  Voriconazole                 Serious invasive mycosis infections                                                                                                                                                                                                                                                                                                                                                                                 Compliance with Authority Required procedures
                                                      Treatment and maintenance therapy
                                                      The treatment must be for invasive mycosis infections other than definite or probable invasive aspergillosis; AND
                                                      Must be treated by a health practitioner who is any of: (i) a medical practitioner, (ii) an authorised PBS prescriber who is not a medical practitioner, but who is: (a) sharing care of the patient with at least one medical practitioner; (b) intending to share care of the patient with a medical practitioner.
C15984  P15984  CN15984  Fluconazole                  Cryptococcal meningitis                                                                                                                                                                                                                                                                                                                                                                                             Compliance with Authority Required procedures - Streamlined Authority Code 15984
                                                      Must be treated by a health practitioner who is any of: (i) a medical practitioner, (ii) an authorised PBS prescriber who is not a medical practitioner, but who is: (a) sharing care of the patient with at least one medical practitioner; (b) intending to share care of the patient with a medical practitioner.
C15994  P15994  CN15994  Fentanyl                     Chronic severe disabling pain                                                                                                                                                                                                                                                                                                                                                                                       Compliance with Authority Required procedures - Streamlined Authority Code 15994
                         Methadone                    Initial PBS treatment after 1 June 2020 where patient has been treated with opioids for more than 12 months
                                                      The condition must require daily, continuous, long term opioid treatment;